September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Driving Performance in Subjects with Glaucomatous Visual Field Loss as Investigated in a Driving Simulator
Author Affiliations & Notes
  • Amir Marvasti
    Shiley Eye Institute, University of California, San Diego, San Diego, California, United States
  • Alberto Diniz-Filho
    Shiley Eye Institute, University of California, San Diego, San Diego, California, United States
  • Erwin R Boer
    Shiley Eye Institute, University of California, San Diego, San Diego, California, United States
  • Peter Rosen
    Shiley Eye Institute, University of California, San Diego, San Diego, California, United States
  • Felipe A Medeiros
    Shiley Eye Institute, University of California, San Diego, San Diego, California, United States
  • Footnotes
    Commercial Relationships   Amir Marvasti, None; Alberto Diniz-Filho, None; Erwin Boer, None; Peter Rosen, None; Felipe Medeiros, Alcon Laboratories Inc (R), Alcon Laboratories Inc (F), Allergan, Inc (C), Allergan Inc (F), Allergan Inc (R), Bausch & Lomb (F), Carl Zeiss Meditec Inc (F), Carl Zeiss Meditec Inc (R), Carl Zeiss Meditec Inc (C), Heidelberg Engineering Inc (F), Merck Inc. (F), National Eye Institute (F), Novartis (C), Reichert, Inc (F), Reichert Inc (R), Sensimed (F), Topcon Inc (F)
  • Footnotes
    Support  Unrestricted grant from Research to Prevent Blindness; fellowship from Brazilian National Council for Scientific and Technological Development (CNPq) 233829/2014-8 (A.D.F.).
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Amir Marvasti, Alberto Diniz-Filho, Erwin R Boer, Peter Rosen, Felipe A Medeiros; Driving Performance in Subjects with Glaucomatous Visual Field Loss as Investigated in a Driving Simulator. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate driving performance in patients with glaucomatous visual field loss in a driving simulator.

Methods : The study included 103 glaucoma patients with repeatable bilateral visual field defects and 79 control subjects. All subjects underwent standard automated perimetry (SAP) and driving performance assessment on a simulator. Average SAP MD of the better and worse eyes of glaucoma patients were -4.60dB and -8.54dB, respectively. The driving simulation protocol consisted of a curve negotiation (CN) task, where the driver had to keep the car in the center lane on a winding road; and a car following (CF) task, where the driver had to follow a lead vehicle at a short distance in a straight road. Several metrics of performance were obtained, including curve and speed coherence, standard deviation of lane position (STLP), time to collision (TTC), STD of speed gain, STD of speed, and lane excursions. In addition, peripheral visual stimuli were presented simultaneously to driving tasks in order to investigate the ability to divide attention. Mean reaction times (RT) to peripheral stimuli were recorded. A global index of driving performance was calculated from principal component analysis of simulator data.

Results : Glaucoma patients showed higher STD of speed (P=0.002) and decreased time to collision (P=0.039), suggesting a riskier behavior during car following task. Mean RT on divided attention tasks were also significantly higher in glaucoma than controls, suggesting impaired ability to divide attention. Mean RT during the curve negotiation task was 1.4±1.2 vs. 0.7±0.3s in glaucoma and controls, respectively (P<0.001). For the car following task, mean RT was 1.4±1.4 vs. 0.8±0.5s, respectively (P<0.001). On average, global driving performance was significantly worse in the glaucoma group compared to controls (0.59±2.96 vs. -0.77±1.47; P<0.001). Twenty-one patients with glaucoma (20.4%) showed impaired driving performance with global performance index above the 95th percentile cutoff calculated from the control group. Glaucoma patients with impaired driving ability showed significantly worse visual field results than those with above average performance (25.5 ± 5.2dB vs. 28.4 ± 3.0dB, P=0.004).

Conclusions : A significant number of glaucoma patients show impaired driving performance as assessed by a driving simulator.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×